Ospedale Unico della Versilia Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2008
NCT00640562
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Ospedale Unico della Versilia (Lido di Camaiore, Lucca Italy)

Active Ingredients

Drugs in Phase 3 Trials (2)

quetiapine (seroquel) (1 trial)

risperidone (risperdal) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 3)

Depressive Disorder (Phase 3)

Schizophrenia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2